Related references
Note: Only part of the references are listed.Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
Subramanian Boopathi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More
Abinit Saha et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States
Bradley Sanville et al.
CLINICAL INFECTIOUS DISEASES (2020)
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment
Miranda Davies et al.
DRUG SAFETY (2020)
An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication
Jesper M. Weehuizen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Corticosteroid use for 2019-nCoV infection: A double-edged sword
Sundus Nasim et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19
Mark A. Marinella
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2020)
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
Biykem Bozkurt et al.
JOURNAL OF CARDIAC FAILURE (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Measurement of body temperature to prevent pandemic COVID-19 in hospitals in Taiwan: repeated measurement is necessary
S-H. Hsiao et al.
JOURNAL OF HOSPITAL INFECTION (2020)
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
Jahan S. Khalili et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
The preventive strategies of community hospital in the battle of fighting pandemic COVID-19 in Taiwan
Chih-Jen Yang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Treatment options for COVID-19: The reality and challenges
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
How to prevent outbreak of a hospital-affiliated dementia day-care facility in the pandemic COVID-19 infection in Taiwan
Hsuan-Ti Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
TRIALS (2020)
Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2
Roberto Gomeni et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Remdesivir in covid-19
Robin E. Ferner et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: Selected NHS patients will be treated with remdesivir
Zosia Kmietowicz
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: Remdesivir is helpful but not a wonder drug, say researchers
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
EGFR Tyrosine Kinase Inhibitor-Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
Hsu-Liang Chang et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Remdesivir for COVID-19: challenges of underpowered studies
John David Norrie
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
Mekonnen Sisay
FRONTIERS IN PHARMACOLOGY (2020)
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Richard T. Eastman et al.
ACS CENTRAL SCIENCE (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series
Pavan K. Bhatraju et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
Niyada Naksuk et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient
Emily Hillaker et al.
PHARMACOTHERAPY (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
E. Susan Amirian et al.
ONE HEALTH (2020)
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
Meagan L. Adamsick et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic
Hsu-Liang Chang et al.
LUNG CANCER (2020)
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson et al.
NATURE (2020)
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
Chengyuan Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Coronavirus envelope protein: current knowledge
Dewald Schoeman et al.
VIROLOGY JOURNAL (2019)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Late Ebola virus relapse causing meningoencephalitis: a case report
Michael Jacobs et al.
LANCET (2016)
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
Sandrine Belouzard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Share Paper
